Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Joint, bone, spine : revue du rhumatisme

• Publication date

  2005-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.JBSPIN.2004.10.004PMID 16038840
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of vaccination, recent use of NSAIDs and antibiotics on Crohn's disease clinical activity. A prospective cohort study

  2003cited by this paper
• A controlled study of NSAID-induced small bowel injury using video capsule endoscopy

  2003cited by this paper
• Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use.

  2003cited by this paper
• An open‐label trial of the selective cyclo‐oxygenase‐2 inhibitor, rofecoxib, in inflammatory bowel disease‐associated peripheral arthritis and arthralgia

  2003cited by this paper
• Anti‐inflammatory drugs, analgesics and the risk of perforated colonic diverticular disease

  2003cited by this paper
• Non-steroidal anti-inflammatory drugs as a risk factor for acute diarrhoea: a case crossover study

  2003cited by this paper
• Neutrophil migration into indomethacin induced rat small intestinal injury is CD11a/CD18 and CD11b/CD18 co-dependent

  2002cited by this paper
• Exacerbation of Crohn's colitis with severe colonic hemorrhage in a patient on rofecoxib.

  2002cited by this paper
• Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease.

  2002cited by this paper
• COX-1 and 2, intestinal integrity, and pathogenesis of nonsteroidal anti-inflammatory drug enteropathy in mice.

  2002cited by this paper
• Safety of selective cyclooxygenase-2 inhibitors in inflammatory bowel disease

  2002cited by this paper
• Exacerbation of Crohn's colitis with severe colonic hemorrhage in a patient on rofecoxib

  2002cited by this paper
• Lymphocytic Colitis: clinical features, treatment, and outcomes

  2002cited by this paper
• Protective role of cyclooxygenase inhibitors in the adverse action of passive cigarette smoking on the initiation of experimental colitis in rats.

  2001cited by this paper
• Exacerbation of inflammatory bowel disease associated with use of celecoxib

  2001cited by this paper
• [Diclofenac-induced colitis complicated by Klebsiella oxytoca infection].

  2001cited by this paper
• Effects of a COX-2 Preferential Agent Nimesulide on TNBS-Induced Acute Inflammation in the Gut

  2001cited by this paper
• Interactive roles of superoxide and inducible nitric oxide synthase in rat intestinal injury provoked by non-steroidal anti-inflammatory drugs.

  2001cited by this paper
• Celecoxib, a selective cyclo-oxygenase-2 inhibitor reduces the severity of experimental colitis induced by dinitrobenzene sulfonic acid in rats.

  2001cited by this paper
• Colite induite par le diclofénac et compliquée d'une infection à Klebsiella oxytoca

  2001cited by this paper
• Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study

  2000cited by this paper
• COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin

  2000cited by this paper
• Role of biliary phosphatidylcholine in bile acid protection and NSAID injury of the ileal mucosa in rats.

  2000cited by this paper
• Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease

  2000cited by this paper
• Uncoupling of intestinal mitochondrial oxidative phosphorylation and inhibition of cyclooxygenase are required for the development of NSAID‐enteropathy in the rat

  2000cited by this paper
• Comparison of the intestinal toxicity of celecoxib, a selective COX-2 inhibitor, and indomethacin in the experimental rat.

  2000cited by this paper
• Cyclo‐oxygenase‐2 inhibitors ameliorate the severity of experimental colitis in rats

  2000cited by this paper
• Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2.

  2000cited by this paper
• [Duodenal diaphragm induced by aspirin].

  2000cited by this paper
• A randomized trial measuring fecal blood loss after treatment with rofecoxib, ibuprofen, or placebo in healthy subjects.

  2000cited by this paper
• Adverse Effects of Nonsteroidal Anti-Inflammatory Drugs on the Small and Large Bowel

  1999cited by this paper
• High prevalence of NSAID enteropathy as shown by a simple faecal test

  1999cited by this paper
• Lack of beneficial effect of COX-2 inhibitors in an experimental model of colitis.

  1999cited by this paper
• Recent considerations in nonsteroidal anti-inflammatory drug gastropathy.

  1998cited by this paper
• A case of sulindac-induced enteropathy resulting in jejunal perforation.

  1998cited by this paper
• A case of sulindac-induced enteropathy resulting in jejunal perforation.

  1998cited by this paper
• [Clostridium difficile pseudo-membranous colitic secondary to taking diclofenac].

  1998cited by this paper
• Effects of inhibition of prostaglandin endoperoxide synthase‐2 in chronic gastro‐intestinal ulcer models in rats

  1998cited by this paper
• Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease.

  1997cited by this paper
• Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice.

  1997cited by this paper
• Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation.

  1997cited by this paper
• Mitochondrial damage: a possible mechanism of the “topical” phase of NSAID induced injury to the rat intestine

  1997cited by this paper
• Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2.

  1996cited by this paper
• Characterization of Prostaglandin G/H Synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts.

  1996cited by this paper
• [Ano-rectal and colonic complications of suppositories and enemas].

  1996cited by this paper
• Nonsteroidal antiinflammatory drug-induced colonic stricture

  1995cited by this paper
• Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse.

  1995cited by this paper
• Leucocyte-endothelial cell adhesion in a model of intestinal inflammation.

  1995cited by this paper
• Benign colonic ulcers associated with nonsteroidal antiinflammatory drug ingestion.

  1994cited by this paper
• Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain.

  1994cited by this paper
• NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions.

  1993cited by this paper
• Diaphragm disease of the ascending colon. Association with sustained-release diclofenac.

  1993cited by this paper
• Non‐steroidal anti‐inflammatory drugs and segmental non‐gangrenous colitis: a case‐control study

  1993cited by this paper
• Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans.

  1993cited by this paper
• Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs.

  1992cited by this paper
• Colitis induced by nonsteroidal anti-inflammatory drugs. Report of four cases and review of the literature.

  1992cited by this paper
• Non-steroidal anti-inflammatory drugs as a possible cause of collagenous colitis: a case-control study.

  1992cited by this paper
• Colonic strictures in a patient on long-term non-steroidal anti-inflammatory drugs.

  1992cited by this paper
• Small bowel enteroscopy in undiagnosed gastrointestinal blood loss.

  1992cited by this paper
• Non‐steroidal anti‐inflammatory drugs and complicated diverticular disease: A case‐control study

  1991cited by this paper
• Stercoral perforation of the colon

  1991cited by this paper
• Non‐steroidal anti‐inflammatory drugs and complicated diverticular disease: A case—control study

  1991cited by this paper
• Anaemia in rheumatoid arthritis: the role of iron, vitamin B12, and folic acid deficiency, and erythropoietin responsiveness.

  1990cited by this paper
• Acute eosinophilic colitis and hypersensitivity reaction associated with naproxen therapy.

  1990cited by this paper
• Role of endogenous prostaglandins in preventing gastrointestinal ulceration: induction of ulcers by antibodies to prostaglandins.

  1989cited by this paper
• Diaphragm disease: pathology of disease of the small intestine induced by non-steroidal anti-inflammatory drugs.

  1988cited by this paper
• Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs.

  1987cited by this paper
• Nonsteroidal antiinflammatory drug-induced intestinal inflammation in humans.

  1987cited by this paper
• Mefenamic acid enteropathy.

  1987cited by this paper
• Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease.

  1987cited by this paper
• Small bowel ulceration in patients receiving non-steroidal anti-inflammatory drugs for rheumatoid arthritis.

  1986cited by this paper
• Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine.

  1986cited by this paper
• Sulindac-associated small bowel lesion.

  1986cited by this paper
• Use of anti-inflammatory drugs by patients admitted with small or large bowel perforations and haemorrhage.

  1985cited by this paper
• Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs.

  1984cited by this paper
• Serum ferritin and the assessment of iron deficiency in rheumatoid arthritis.

  1983cited by this paper
• Enteritis and colitis associated with mefenamic acid.

  1983cited by this paper
• Intestinal perforation associated with osmotic slow release indomethacin capsules.

  1983cited by this paper
• Role of bacteria in gastric ulceration produced by indomethacin in the rat: cytoprotective action of antibiotics.

  1983cited by this paper
• Prostaglandin synthesis inhibitors in ulcerative colitis: flurbiprofen compared with conventional treatment.

  1981cited by this paper
• Effects of cholestyramine and synthetic hydrotalcite on acute gastric or intestinal lesion formation in rats and dogs

  1981cited by this paper
• Gastrointestinal perforation following indomethacin therapy in very low birth weight infants.

  1981cited by this paper
• Resistance of germfree rats to indomethacin-induced intestinal lesions.

  1977cited by this paper
• An intestinal disease produced experimentally by a prostaglandin deficiency.

  1975cited by this paper

• Colonic Diaphragmatic Disease: The Concerning Dark Depths of NSAIDs

  2025cites this paper
• From pain relief to mucosal grief: A comprehensive review of NSAID enteropathy.

  2025cites this paper
• Saudi Clinical Practice Guidelines for Management of Axial Spondyloarthritis Disease

  2025cites this paper
• Adverse Reactions With VEGF Inhibitors in Combination With NSAIDs: Disproportionality Analysis Using JADRE and FAERS

  2025cites this paper
• Concurrent analysis of six NSAIDs in human plasma using polyurethane/B-N-S-co-doped rGO nanofiber-modified glassy carbon electrode followed by EA-SPME.

  2025cites this paper
• “Isolation and Characterization of Steroidal Alkaloids from Sarcococca Saligna, Their Antinociceptive, Anti‐Inflammatory, and Gastroprotective Effect in Animal's Model”

  2025cites this paper
• Recent progress in adverse events of carboxylic acid non-steroidal anti-inflammatory drugs (CBA-NSAIDs) and their association with the metabolism: the consequences on mitochondrial dysfunction and oxidative stress, and prevention with natural plant extracts

  2024cites this paper
• Occurrence, toxicity, impact and removal of selected non-steroidal anti-inflammatory drugs (NSAIDs): A review.

  2023cites this paper
• Research progress of non-steroidal anti-inflammatory drug-induced small intestinal injury

  2021cites this paper
• Medical treatment of pouchitis: a guide for the clinician

  2021cites this paper
• An Unusual Case of Colon Perforation With Multiple Transmural Ulcers After Use of Polmacoxib and Everolimus in a Metastatic Breast Cancer Patient

  2020cites this paper
• In vitro Anti-inflammatory Effects of Satureja Kkhuzestanica Essential Oil Compared to Carvacrol

  2020cites this paper
• Gut dysbiosis, leaky gut, and intestinal epithelial proliferation in neurological disorders: towards the development of a new therapeutic using amino acids, prebiotics, probiotics, and postbiotics

  2019cites this paper
• Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial

  2019cites this paper
• Drugging cancer metabolism: Expectations vs. reality.

  2019cites this paper
• Mud-bath treatment of seronegative spondyloarthritis: experience at the Euganean Thermal Area

  2019cites this paper
• Mouse Model of Mutated in Colorectal Cancer Gene Deletion Reveals Novel Pathways in Inflammation and Cancer

  2019cites this paper
• Balneotherapy in chronic inflammatory rheumatic diseases—a narrative review

  2018cites this paper
• The colon and terminal ileum in patients with ankylosing spondylitis and controls in Bangladesh: a macroscopic and microscopic study

  2018cites this paper
• Small Bowel Perforations

  2018cites this paper
• Complications related to chronic supratherapeutic use of codeine containing compound analgesics in a cohort of patients presenting for codeine withdrawal

  2018cites this paper
• Pharmacological Approach for Managing Pain in Irritable Bowel Syndrome: A Review Article

  2017influential citation
• Review article: a practical approach to the clinical management of NSAID enteropathy

  2017cites this paper
• Association between NSAIDs and Clostridium difficile-Associated Diarrhea: A Systematic Review and Meta-Analysis

  2016cites this paper
• The Effect of DA-6034 on Intestinal Permeability in an Indomethacin-Induced Small Intestinal Injury Model

  2016cites this paper
• Optimization of spray-dried diclofenac sodium-loaded microspheres by screening design

  2016cites this paper
• Tube digestif et traitements anti-inflammatoires (AINS, corticoïdes)

  2016cites this paper
• DEVELOPMENT OF SUSTAINED RELEASE MICROPARTICLES OF DICLOFENAC SODIUM USING STEARIC ACID AS POLYMER BY EMULSION/CHILLING METHOD

  2016cites this paper
• The Antiinflammatory Properties of Humic Substances: A Mini Review

  2015cites this paper
• The Antiinflammatory Properties of Humic Substances: A Mini Review.

  2015cites this paper
• Optimization of sustained release aceclofenac microspheres using response surface methodology.

  2015cites this paper
• Sulindac reversal of 15-PGDH-mediated resistance to colon tumor chemoprevention with NSAIDs.

  2015cites this paper
• Medikamentös induzierte Schäden im Gastrointestinaltrakt

  2015cites this paper
• Carprofen-induced oxidative stress in mitochondria of the colonic mucosa of the dog.

  2014cites this paper
• NSAID-Induced Enteropathy: Are the Currently Available Selective COX-2 Inhibitors All the Same?

  2014cites this paper
• Prevalence and risk factors of Clostridium difficile infection in patients hospitalized for flare of inflammatory bowel disease: a retrospective assessment.

  2014cites this paper
• Aceclofenac microspheres: quality by design approach.

  2014cites this paper
• Apoptotic enteropathy caused by antimetabolites and TNF-α antagonists

  2014cites this paper
• Small bowel ulcerative lesions are common in elderly NSAIDs users with peptic ulcer bleeding.

  2014cites this paper
• Cherry-tree colon: colonoscopic appearance suggesting drug-induced mucosal injury

  2014cites this paper
• Reactive Oxygen Species‐Scavenging Nanomedicines for the Treatment of Oxidative Stress Injuries

  2014cites this paper
• [The up-to-date methods of management of NSAIDs-induced injuries of small intestine].

  2014influential citation
• Effect of Aspirin on Morphometrical Changes of Intestinal Villus Length and Epithelial Thickness in Rat Embryos

  2014cites this paper
• Sodium alginate/HPMC/liquid paraffin emulsified (o/w) gel beads, by factorial design approach; and in vitro analysis

  2014cites this paper
• TOXICOLOGICAL PATHOLOGY OF NAPROXEN (NSAIDS) ON GASTRO-INTESTINAL TRACT IN WHITE RATS

  2014cites this paper
• Tolerability of selective cyclooxygenase 2 inhibitors used for the treatment of rheumatological manifestations of inflammatory bowel disease.

  2014cites this paper
• Suppression of NSAID-induced small intestinal inflammation by orally administered redox nanoparticles.

  2013cites this paper
• Prenatal exposure of diclofenac sodium affects morphology but not axon number of the median nerve of rats.

  2013cites this paper
• Pharmacokinetics and pharmacodynamics of some NSAIDs in horses: A pharmacological, biochemical and forensic study

  2013cites this paper
• Sulindac activates NF-κB signaling in colon cancer cells

  2013cites this paper
• Diclofenac Sodium-Loaded Eudragit® Microspheres: Optimization Using Statistical Experimental Design

  2013cites this paper
• THE ESTIMATION OF EFFECTIVENESS AND SAFETY OF TREATMENT WITH COMBINATION OF APROXEN+ESOMEPRAZOLE (VIMOVO) IN PATIENTS WITH OSTEOARTROSIS

  2013cites this paper
• THE WAY TO MODEL THE IMPARED POST-TRAUMATIC REGENERATION OF TIBIA

  2013cites this paper
• Prognosis and follow-up of 135 patients with ischemic colitis over a five-year period.

  2013cites this paper
• A 9-year evaluation of temporal trends in alosetron postmarketing safety under the risk management program

  2013cites this paper
• Pathogenesis of non steroidal anti inflammatory drug NSAID induced renal damage

  2013cites this paper
• Proton pump inhibitors are not the key for therapying non-steroidal anti-inflammatory drugs-induced small intestinal injury

  2013cites this paper
• Targeting cyclooxygenase-2 in depression is not a viable therapeutic approach and may even aggravate the pathophysiology underpinning depression

  2012cites this paper
• Protective effect of aqueous extract of Spinacia oleracea leaves in experimental paradigms of inflammatory bowel disease

  2012cites this paper
• The Role of COX-2 Inhibitors on Experimental Colitis

  2012cites this paper
• Bioactivity-Guided Isolation of Ethyl-p-methoxycinnamate, an Anti-inflammatory Constituent, from Kaempferia galanga L. Extracts

  2012cites this paper
• The role of nonsteroidal antiinflammatory drugs and cyclooxygenase-2 inhibitors on experimental colitis.

  2012cites this paper
• Diazoxide attenuates indomethacin-induced small intestinal damage in the rat.

  2011cites this paper
• Haemoglobin decreases in NSAID users over time: an analysis of two large outcome trials

  2011cites this paper
• Zinc protects against indomethacin-induced damage in the rat small intestine.

  2011cites this paper
• Clinical patterns and outcomes of ischaemic colitis: Results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study)

  2011cites this paper
• La diarrhée médicamenteuse

  2011cites this paper
• Prevention and management of non-steroidal anti-inflammatory drugs-induced small intestinal injury.

  2011cites this paper
• Non-steroidal anti-inflammatory drugs – potential risks and benefits in the gastrointestinal tract distal to the ligament of Treitz

  2010cites this paper
• Ischemic Colitis and Complications of Constipation Associated With the Use of Alosetron Under a Risk Management Plan: Clinical Characteristics, Outcomes, and Incidences

  2010cites this paper
• Gastrointestinal and liver side effects of drugs in elderly patients.

  2010cites this paper
• cPLA2 is protective against COX inhibitor-induced intestinal damage.

  2010cites this paper
• Non-steroidal anti-inflammatory drugs - potential risks and benefits in the gastrointestinal tract distal to the ligament of Treitz Niesteroidowe leki przeciwzapalne - potencjalne zagrożenia i korzyści dla przewodu pokarmowego dystalnie do więzadła Treitza

  2010cites this paper
• The NSAID sulindac is chemopreventive in the mouse distal colon but carcinogenic in the proximal colon

  2010cites this paper
• [Unsolved problems of enteropathy induced by nonsteroidal anti-inflammatory drugs].

  2009cites this paper
• Naproxen-Induced Anemia and Hypoalbuminemia in a 16-Month-Old Child

  2009influential citation
• Exacerbation of inflammatory bowel diseases associated with the use of nonsteroidal anti-inflammatory drugs: myth or reality?

  2009cites this paper
• Diaphragm disease of the jejunum.

  2009cites this paper
• Effects of oral curcumin on indomethacin-induced small intestinal damage in the rat.

  2009cites this paper
• Colonic perforation after short-term use of nonsteroidal antiinflammatory drugs: report of two cases

  2009cites this paper
• Nursing management of patients with severe ulcerative colitis

  2009cites this paper
• Fibrosing colonopathy associated with treatment with enteric-coated mesalazine pills.

  2009cites this paper
• Nonsteroidal antiinflammatory drugs投与によると考えられた大腸穿孔・穿通の2例

  2009cites this paper
• Lupus mesenteric vasculitis can cause acute abdominal pain in patients with SLE

  2009cites this paper
• NSAIDs-induced diaphragm-like colonic strictures: a case report

  2009cites this paper
• [Diverticular disease of the colon: diagnosis and treatment. Consensus Conference, 5th National Congress of the Italian Society of Academic Surgeons].

  2009cites this paper
• Improvement in hemoglobin levels in patients with ankylosing spondylitis treated with infliximab.

  2009cites this paper
• Curcumin attenuates indomethacin-induced oxidative stress and mitochondrial dysfunction

  2008cites this paper
• [The safety of COX-2 inhibitors].

  2008cites this paper
• Effect of Indomethacin on MatrixMetalloproteinases in the Rat Kidney: Does Zinc affect these Changes?

  2008cites this paper
• Clinical Efficacy of Esomeprazole in the Prevention and Healing of Gastrointestinal Toxicity Associated with NSAIDs in Elderly Patients

  2008cites this paper
• Early changes in the lipoperoxidation processes and structure components of the mucous membrane of large intestine in rats under the blockage of COX-2

  2008cites this paper
• Acute effects of carprofen and meloxicam on canine gastrointestinal permeability and mucosal absorptive capacity.

  2007cites this paper
• Antibiotics Protect against Septic Shock in Mice Administered β‐Glucan and Indomethacin

  2007cites this paper
• Una causa infrecuente de suboclusión intestinal en una paciente con artritis reumatoide

  2007cites this paper
• IL-17 Axis → Disease Is Mediated through the IL-23 in Experimental Inflammatory Bowel 2 E The Proinflammatory Effect of Prostaglandin

  2007cites this paper
• Carprofen compromises the integrity and barrier function of the colonic mucosa of the dog

  2007cites this paper
• Mud-bath treatment in spondylitis associated with inflammatory bowel disease--a pilot randomised clinical trial.

  2007cites this paper
• Pathological effects caused by chronic treatment of rainbow trout with indomethacin.

  2007cites this paper
• Gastrointestinal safety of novel nonsteroidal antiinflammatory drugs: selective COX-2 inhibitors and beyond.

  2007cites this paper